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Abstract
Current treatments for reversible blindness caused by corneal endothelial cell failure involve replacing the failed
endothelium with donor tissue using a one donor-one recipient strategy. Due to the increasing pressure of a worldwide
donor cornea shortage there has been considerable interest in developing alternative strategies to treat endothelial
disorders using expanded cell replacement therapy. Protocols have been developed which allow successful expansion of
endothelial cells in vitro but this approach requires a supporting material that would allow easy transfer of cells to the
recipient. We describe the first use of plastic compressed collagen as a highly effective, novel carrier for human corneal
endothelial cells. A human corneal endothelial cell line and primary human corneal endothelial cells retained their
characteristic cobblestone morphology and expression of tight junction protein ZO-1 and pump protein Na+/K+ ATPase a1
after culture on collagen constructs for up to 14 days. Additionally, ultrastructural analysis suggested a well-integrated
endothelial layer with tightly opposed cells and apical microvilli. Plastic compressed collagen is a superior biomaterial in
terms of its speed and ease of production and its ability to be manipulated in a clinically relevant manner without breakage.
This method provides expanded endothelial cells with a substrate that could be suitable for transplantation allowing one
donor cornea to potentially treat multiple patients.
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Introduction
The cornea is our transparent window to the world and its
integrity and transparency are essential for proper functioning of
the eye. The cornea is a highly organised tissue with three distinct
cellular layers and two acellular layers. The acellular Descemet’s
membrane separates the cellular stroma from the innermost
endothelial layer, which is a monolayer of cells in direct contact
with the aqueous humour of the anterior chamber. The corneal
endothelial layer is responsible for the maintenance of corneal
transparency by acting as a ‘‘leaky’’ barrier to allow nutrients to
flow from the aqueous humour in the anterior chamber into the
collagen stroma and then preventing swelling by actively pumping
excess fluid out. This state of equilibrium is lost in disorders such as
Fuchs endothelial dystrophy, which is characterised by a
progressive oedema of the cornea, due to a loss of endothelial
cell density. Fuchs is the most commonly occurring dystrophy in
the US affecting approximately 4% of the population over the age
of 40 [1]. For treatment of disorders such as Fuchs, several
posterior lamellar techniques have been described as an alternative
to the traditional full thickness corneal replacement known as
penetrating keratoplasty (PK). These lamellar techniques replace
only the defective endothelial layer and include Descemet’s
stripping (automated) endothelial keratoplasty (DSEK (or
DSAEK)) and Descemet’s membrane endothelial keratoplasty
(DMEK). There are many advantages to the lamellar techniques
over the PK procedure because the corneal surface is not
compromised allowing for faster visual recovery, suture related
problems are eliminated as endothelial keratoplasty requires no
corneal sutures and wound healing complications are rare as the
procedure can be performed through a self-sealing limbal or
scleral tunnel incision at the periphery of the cornea [2,3].
Although these new techniques are an improvement on the
classic PK method, the worldwide donor cornea shortage is
increasingly becoming an issue [4], compounded by the fact that
demand for corneal transplantation is expected to increase due to
a rise in the aging population globally [5]. This has led to
considerable interest in the development of a strategy to treat
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endothelial disorders using cell replacement therapy as an
alternative to one donor – one recipient tissue transplants. The
considerable challenge here is that corneal endothelial cells are
maintained in a G1 cell cycle phase arrested state and do not
proliferate in vivo [6]. However, these cells do retain their
proliferative capacity and many research groups have successfully
stimulated cell division in order to expand endothelial cell
numbers in vitro [7–10]. Expanded cell therapy could potentially
allow many patients to be treated using one donor cornea and may
alleviate some of the current donor shortage problems. However,
this approach requires a supporting material with properties
enabling easy transfer of the propagated cells to the recipient while
at the same time exhibiting no detrimental effect on the
functionality of the endothelial cell population [11].
We have developed a process of plastic compression of type 1
collagen hydrogels to produce a thin (60–200 mm) collagen
membrane-like construct with enhanced mechanical properties,
which we have termed Real Architecture For 3D Tissues (RAFT).
If required, RAFT can be seeded directly with cells in the collagen
before compression and we have previously shown it to be suitable
for the generation of a human corneal epithelial cell surface layer
[12]. The major advantage of RAFT is its rapid, simple and
reproducible method of production and ability to be easily
manipulated, particularly important if they are to be handled by
surgeons for transplantation. Here we describe the first use of
plastic compressed RAFT as a highly effective, novel carrier for
cultured human corneal endothelial cells for transplantation.
Materials and Methods
Ethics Statement
All human tissue was handled according to the tenets of the
Declaration of Helsinki and written consent was acquired from
next of kin of all deceased donors regarding eye donation for
research. This study was approved by the institutional review
board of the Singapore Eye Research Institute/Singapore
National Eye Centre.
Donor Tissue
Cadaveric donor corneal rims with appropriate written research
consent from next of kin were obtained from the Florida Lions Eye
Bank (Miami, FL, USA). Three donor cornea pairs were used with
donor age ranging from 15–24 years of age. Corneas were stored
at 4uC in Optisol GS (Chiron Ophthalmics Inc., Irvine, California)
and used within 13 days of enucleation.
Isolation and Culture of Human Corneal Endothelial Cells
Human corneal endothelial cells (hCECs) were isolated using a
2-step peel and digest method as previously described [7]. Briefly,
corneas were incubated in three washes of antibiotic/antimycotic
solution in phosphate buffered saline (PBS; Life Technologies,
Ltd., Paisley, UK) and then endothelial layer and Descemet’s
membrane were removed for incubation with collagenase A
(Sigma-Aldrich Ltd., Dorset, UK) for up to 6 hours at 37uC. Cell
clusters were then subjected to TrypLE Express (Life Technolo-
gies, Ltd., Paisley, UK) treatment for 5 min at 37uC to disperse the
cell clumps. Cells were then seeded onto fibronectin/collagen
(FNC) coating mix (US Biologicals, MA, USA) coated 6 cm
culture dishes (Falcon; BD Biosciences, Oxford, UK). Cells were
cultured in human endothelial culture medium based on
Engelmann’s F99 medium [13] with slight modifications as
previously described [7]. Medium contained Ham’s F12:Medium
199 (1:1), 5% foetal bovine serum, 10 ng/ml bFGF (all Life
Technologies, Ltd., Paisley, UK), 20 mg/ml ascorbic acid, 20 mg/
ml bovine insulin, 2.5 mg/ml transferrin and 0.6 ng/ml sodium
selenite (all Sigma-Aldrich Ltd., Dorset, UK). Cell culture medium
was changed every other day. Cells were sub-cultured after
dissociation using TrypLE Express when confluent. Cells at
passage 2 or 3 were seeded onto RAFT. Phase contrast images
were taken to assess cell morphology using a Nikon TS100
microscope with a Nikon DS-FiI digital camera.
Culture of the Human Corneal Endothelial Cell Line
A human corneal endothelial cell line (hCECL) was cultured as
per supplier’s instructions (B4G12; DSMZ, Germany). Cells were
seeded onto chondroitin sulphate and laminin (CS/L; both Sigma-
Aldrich Ltd., Dorset, UK) coated dishes (Corning Life Sciences,
Amsterdam, Netherlands) in culture medium consisting of human
endothelial-SFM (Life Technologies, Ltd., Paisley, UK) supple-
mented with 10 ng/ml bFGF (Sigma-Aldrich Ltd., Dorset, UK).
Cell culture medium was changed every 2 days and cells passaged
using 0.05% trypsin solution (Life Technologies, Ltd., Paisley, UK)
before reaching confluence. Trypsin was neutralised using
protease inhibitor cocktail (Roche Diagnostics, West Sussex, UK)
and cells seeded at 2000 cells/mm2.
Preparation of Collagen Solution
Collagen gels were prepared by sodium hydroxide (Sigma
Aldrich, Dorset, UK) neutralization of a solution that finally
comprised 80% vol/vol sterile rat-tail type I collagen (2.06 mg
ml-1; First Link, Birmingham, UK) and 10% vol/vol 10x
Minimum Essential Medium (Life Technologies, Ltd., Paisley,
UK). After neutralisation, the final 10% vol/vol hCEC medium
was added. This solution was then left on ice for 30 min to prevent
gelling while allowing dispersion of any small bubbles within the
solution before casting in well plates.
Plastic Compression of Collagen Gels
Collagen gels were plastic compressed using a confined flow
compression method. A volume of 2.2 ml of collagen solution was
added to each well of a 12 well plate (Nunc; Fisher, Loughbor-
ough, UK). Well plates were incubated at 37uC for 30 min to
allow the collagen to undergo fibrillogenesis. Once the gels were
set they were subjected to a confined compression (Fig. 1). Briefly,
a sterile nylon mesh and a sterile filter paper circle were placed
directly on top of a collagen gel and then a chromatography paper
Figure 1. Plastic compression process. Schematic diagram
showing the confined flow plastic compression process in a 12 well
plate format to create RAFT.
doi:10.1371/journal.pone.0050993.g001
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roll was added. A 35 g load was then applied to the system for
15 min to allow compression of the collagen gel with loss of fluid in
a confined, upward flow direction through the paper roll. This
process yielded a thin collagen construct, that we have termed
RAFT, which was then either kept in place in a 12 well plate for
hCECL culture or trephined using a 8.25 mm trephine (Coronet,
Network Medical Products Ltd., Ripon, UK) to obtain small discs
for hCEC culture. The trephined discs were transferred to an
organ culture dish (Falcon; BD Biosciences, Oxford, UK) and
maintained in a small amount of PBS until cell seeding. The
thickness of representative RAFT constructs was then measured
using optical coherence tomography (OCT) with an anterior
segment lens (Spectralis, Heidelberg Engineering, Hemel Hemp-
stead, UK). Thickness was measured at 3 positions along the
length of a scanned area in the centre of each of three replicate
constructs.
Ease of Handling of RAFT for Transplantation
Porcine whole globes were obtained from First Link Ltd.,
Birmingham, UK. Excess tissue was dissected from the scleral
globe to clean the eyes. Acellular RAFT constructs were prepared
as above and 8.25 mm discs were trephined. A RAFT disc was
placed onto the donor well of the Tan EndoGlideTM preparation
base using a metal spatula. RAFT was then pulled into the
cartridge using loading forceps as per manufacturer’s instructions.
A 4 mm wound was made in the sclera to allow insertion of the
Tan EndoGlideTM and a small incision made on the opposing side
to allow insertion of forceps. The anterior chamber was
maintained by attachment of an infusion of saline at a height of
40 cm via a 28-gauge needle through the cornea into the anterior
chamber. The RAFT construct was then pulled from the cassette
into the anterior chamber using a pull- through technique. Once
free floating in the anterior chamber, a bubble of air was
introduced behind the RAFT construct to maintain its apposition
with the posterior stroma. Representative photographs were taken
of the loading and insertion procedures as seen through a
dissecting microscope, (SMZ1500, Nikon, Kingston upon Thames,
UK).
Seeding of Endothelial Cells onto RAFT
RAFT constructs were coated with either FNC coating mix or
CS/L and then hCECLs were seeded onto the surface in 12 well
plates at a density of 2000–4000 cells/mm2 in a volume of 2 ml
medium. Primary hCECs were seeded onto FNC coated RAFT
discs in organ culture dishes at a density of 2000–3000 cells/mm2
in a volume of 20 ml. Several hours later, after cells had attached,
wells were flooded with endothelial cell culture medium. Dishes
were placed in an incubator at 37uC with 5% CO2 in air. Cell
culture medium was changed every other day and constructs fixed
for staining on day 4 or day 14 for longer-term cultures.
Histological Staining of Paraffin Embedded Sections
Human central corneal specimens and RAFT constructs with
hCECL on the surface were fixed for 30 min with 4% PFA before
processing for paraffin embedding. Tissue sections (6 mm) were cut
on a microtome, rehydrated through alcohols to water, stained
with haematoxylin and eosin, mounted and coverslipped with
DPX. Sections were imaged using a Zeiss 510 Microscope and
Axiovison software.
Immunostaining of Endothelial Cells on RAFT
RAFT constructs with hCECL and hCECs on the surface or
hCECL and hCECs cultured on permanox or glass slides
respectively were fixed with 100% ice-cold ethanol on day 4 or
day 14 (hCECs). Constructs were then blocked in 10% normal
goat serum for 30 min before addition of the primary antibody in
blocking buffer for 1 hour at room temperature. Mouse anti-
human ZO-1 (IgG1, 1:50; BD Biosciences, Oxford, UK) and
mouse monoclonal Na+K+ adenosine triphosphatase (ATPase;
IgG1, 1:40; Santa Cruz, Biotechnology, Heidelberg, Germany)
were used. Negative controls were cells incubated with an anti-
mouse IgG1 isotype control (Biolegend UK Ltd., Cambridge,
UK). After washing in PBS, secondary antibody Alexa Fluor 488
(1:750; Life Technologies, Ltd., Paisley, UK) was incubated with
constructs at room temperature for 30 min. Constructs were then
mounted on slides with vectorshield mounting medium with 49,6-
Figure 2. Loading and insertion of RAFT into an ex vivo porcine eye using Tan EndoGlideTM. Representative photographs showing the
process of loading (A–D) of the Tan EndoGlideTM with RAFT construct and insertion (E–H) of RAFT into the anterior chamber of an ex vivo porcine eye
model. (A) Loading forceps grasp the edge of the RAFT construct from the spatula. (B) RAFT is pulled into the cassette and (C) automatically coils into
a double coil configuration. (D) RAFT is fully loaded into the cassette with no upper surfaces touching. (E) Tan EndoGlide TM is inserted into the
anterior chamber that is prevented from collapsing using a column of saline via an inserted needle. (F) RAFT is pulled from the cassette (G) into the
anterior chamber and positioned centrally before (H) an air bubble is inserted to appose RAFT to the posterior cornea.
doi:10.1371/journal.pone.0050993.g002
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diamidino-2-phenylindole (DAPI; Vector Labs, Peterborough,
UK) or propidium iodide (PI, Sigma-Aldrich Ltd., Dorset, UK)
and sealed with nail varnish for imaging on a Zeiss Imager
microscope with Axiovision software (hCECs) or a Zeiss LSM 510
confocal microscope (hCECL).
Figure 3. Morphology of cultured cells on RAFT. Phase contrast images of (A) hCECL and (B) primary hCECs on tissue culture plastic. Cells on
RAFT, (C) hCECL seeded at a density of 2000 cells/mm2 (D) primary hCECs at 2000 cells/mm2 (E) hCECL at 3000 cells/mm2 and (F) primary hCECs at
3000 cells/mm2. Inset in (C) shows RAFT with no cells on the surface. Scale bars 100 mm.
doi:10.1371/journal.pone.0050993.g003
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Figure 4. Comparison of conformation of cells in human cornea with cells on RAFT. Haematoxylin and eosin stained sections of (A) human
corneal stroma (CS) and endothelial cell layer (ECL) separated by the Descemet’s membrane (DM), (B) hCECL (ECL) on RAFT (R) and (C) toluidine blue
and fuschin stained primary hCECs (ECL) on RAFT (R). Scale bars 50 mm.
doi:10.1371/journal.pone.0050993.g004
Figure 5. Immunochemical analysis of hCECL cells on RAFT. hCECL seeded on RAFT (A) at 3000 cells/mm2 with C/L coating or (B) 3000 cells/
mm2 on FNC coating stained with ZO-1 (green) and counterstained with propidium iodide (red). hCECL seeded on RAFT (C) at 2000 cells/mm2 with C/
L coating or (D) seeded at 4000 cells/mm2 on FNC coating stained with Na+/K+-ATPase (green) and counterstained with propidium iodide. (E)
Negative isotype control. (F) hCECL on permanox slides with FNC coating stained with Na+/K+-ATPase (green) and counterstained with propidium
iodide. Scale bars 50 mm.
doi:10.1371/journal.pone.0050993.g005
PC Collagen for Endothelial Transplantation
PLOS ONE | www.plosone.org 5 November 2012 | Volume 7 | Issue 11 | e50993
Endothelial Cell Density and Cell Size on RAFT
Cell density of hCECs was measured by counting cell numbers
in at least 4 fields of view from 4 different RAFT constructs seeded
with cells. The number of cells per mm2 was then calculated. The
average size of hCECs and hCECL cells was calculated by taking
the area of field of view and dividing by average cell number per
field to determine approximate cell area in mm26 SEM. An
unpaired t-test was performed to determine statistical significance
with values deemed to be significant if p,0.05.
Electron Microscopy Analysis of Endothelial Cells on RAFT
RAFT constructs were examined using transmission electron
microscopy (TEM). RAFT constructs were fixed with 2%
paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.4 (Electron Microscopy Sciences (EMS),
Hatfield, PA, USA) at 4uC overnight. Constructs were then
washed in sodium cacodylate buffer and post-fixed in 1% osmium
tetroxide and potassium ferrocyanide (EMS) to enhance mem-
brane contrast. After extensive rinsing with distilled water, tissues
were dehydrated in a graded series of ethanol, and embedded in
Araldite (EMS). Semi-thin sections of 0.5–1 mm were cut with a
Reichert-Jung Ultracut E Ultramicrotome (C. Reichert Optische
Werke AG, Vienna, Austria), counterstained with toluidine blue/
basic fuchsin and examined using an Axioplan, Zeiss light
microscope (Carl Zeiss, Germany). The ultra-thin sections of 60–
80 nm thickness were cut and collected on copper grids, double
stained with uranyl acetate and lead citrate for 20 min each, then
viewed and imaged at 100 kV on a Philips EM 2085 transmission
electron microscope (FEI Electron Optics BV, Eindoven, Nether-
lands). For scanning electron microscopy (SEM), specimens were
immersed in a fixative containing 2% glutaraldehyde, 2%
paraformaldehyde and 0.1 M sodium cacodylate (pH 7.4) over-
night at 4uC. They were then transferred and stored in sodium
cacodylate buffer (EMS). Before processing, the samples were
washed twice in distilled water and were secondary fixed in 1%
osmium tetroxide (FMB, Singapore), for 2 hours at room
temperature. Following this, samples were dehydrated, critical
point dried (Bal-Tec, Liechtenstein, Germany) and mounted on
SEM stubs using carbon adhesive tabs and finally sputter coated
with a thin layer of gold (10 nm; Bal-Tec). Samples were imaged
Figure 6. Immunochemical analysis of primary hCECs on RAFT. Primary hCECs seeded on glass slides and fixed after 4 days, stained with (A)
ZO-1 or (B) Na+/K+-ATPase (green) counterstained with DAPI (blue). Primary hCECs seeded onto RAFT stained with either (C and E) ZO-1, (D and F)
Na+/K+-ATPase (green) counterstained with DAPI (blue). (C and D) fixed after 4 days in culture or (E and F) after 14 days. Scale bars 50 mm.
doi:10.1371/journal.pone.0050993.g006
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with a field-emission SEM (XL 30 FEG SEM; FEI Company/
Philips, Eindoven, The Netherlands) at 10 kV.
Results
Ease of Handling of RAFT for Transplantation
Acellular RAFT constructs were created and trephined into
8.25 mm discs. To demonstrate ease of handling of RAFT for
transplantation, we used a Tan EndoGlideTM insertion system that
is used clinically to deliver DMEK or DSEK tissue to the anterior
chamber. RAFT could be successfully loaded into the Tan
EndoGlideTM system (Fig. 2A–C), curling inwards in the intended
manner that would protect the endothelial layer as it does for
DMEK (Fig. 2D). An ex vivo porcine eye model was used to
confirm that RAFT could be successfully delivered from the Tan
EndoGlideTM to the anterior chamber through a typical 4 mm
scleral wound using a pull-through technique (Fig. 2E–G). After
removal of all instruments and injection of an air bubble to
position RAFT apposed to the posterior stroma, it is possible to see
that RAFT remains fully intact with no signs of tearing after the
full surgical procedure (Fig. 2H), suggesting the material has
suitable mechanical properties to enable transplantation.
Culture of Human Endothelial Cells on RAFT
RAFT thickness before cell seeding was assessed using OCT
and found to be on average 74.162.04 mm (mean6 SD). The
morphology of endothelial cells on tissue culture plastic and on the
surface of RAFT was then assessed using light microscopy. The
hCECL grew in strict monolayer formation comprising small
polygonal cells when cultured on CS/L coated tissue culture
plastic (Fig. 3A). hCECs expanded and then passaged (up to
passage 3) on FNC coated tissue culture plastic displayed a
polygonal morphology typical of human corneal endothelium
(Fig. 3B). hCECL and hCECs were seeded at varying densities
onto RAFT to determine the optimum seeding density to produce
a confluent monolayer. The background topology of acellular
RAFT caused some interference with cell image capture (Fig. 3C
inset). However, on closer inspection and in comparison to
acellular constructs, cell morphology could still be discerned.
When seeding either hCECL (Fig. 3C) or hCECs (Fig. 3D) at 2000
cells/mm2, cells attached within hours and after 24 hours had
Figure 7. Scanning electron microscope characterisation of RAFT with hCECs. (A) Representative micrograph of the surface of RAFT
constructs. (B) Representative low magnification SEM image showing confluent monolayer of hCECs on RAFT. (C) Higher magnification image
showing cell borders between cells and (D) at high magnification over-lapping finger-like projections onto juxtaposed cells. Scale bars A 5 mm, B
50 mm, C 10 mm, D 2 mm.
doi:10.1371/journal.pone.0050993.g007
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formed a monolayer on the RAFT surface. The same was true for
both hCECL (Fig. 3E) and hCECs (Fig. 3F) seeded at 3000 cells/
mm2 and there was no discernable difference between the cells at
this 24-hour time point. The final cell density of hCECs after 4
days culture on RAFT seeded at a density of 2000 cells/mm2 was
calculated and found to be on average 1941.2 cells/mm2.
Conformation of Endothelial Cell Layers on RAFT
Tissue sections of human cornea and endothelial cells on RAFT
were stained with haematoxylin and eosin or toluidine blue and
basic fuschin to reveal similarities in conformation of the cells on
RAFT compared to native tissue. Human endothelial cells line the
posterior portion of the cornea in a single monolayer separated
from the collagen stroma by the Descemet’s membrane (Fig. 4A).
hCECL on RAFT form a confluent monolayer on the collagen
surface (Fig. 4B) that is very similar to the formation seen in
corneal specimens. The same can be said for hCECs seeded onto
RAFT where an endothelial monolayer can be seen (Fig. 4C).
Endothelial Cell Marker Expression of Cells on RAFT
The effect of cell density and surface coating on the expression
of ZO-1 and Na+ K+ -ATPase was tested using the hCECL. No
apparent differences were seen in the pattern of ZO-1 expression
in cells seeded onto RAFT at 3000 cells/mm2 on CS/L coating
compared with FNC coating (Fig. 5A and B, respectively). Equally,
cells seeded at different concentrations, 2000 compared with 4000
cells/mm2, showed comparable expression patterns of Na+/K+-
ATPase (Fig. 5C and D, respectively). This consistent pattern of
high expression at cell borders of cells on RAFT also matched that
of cells on permanox slides coated with FNC coating (Fig. 5F),
whereas representative negative isotype controls showed no
staining in these areas (Fig. 5E). The average cell area of hCECs
on RAFT was 614.86157.6 mm2 compared with 185.1614.5 mm2
for hCECL cells, which was a significant difference (p,0.05). The
large variability in cell size observed with hCECs is fairly typical of
cells in primary cultures compared to the often homogenous cell
lines. In both cases hCECs expressed ZO-1 (Fig. 6A and C) and
Na+/K+-ATPase (Fig. 6B and D) in abundance whether on glass
Figure 8. Transmission electron microscope characterisation of hCECs on RAFT. (A) Representative image showing apical microvilli (AV) on
the endothelial surface of cells attached to collagen RAFT (Col). (B) Representative image showing tight junctions (TJs) between adjacent cells on
collagen RAFT (Col). (C) Further evidence of tight junctions (TJs) at higher magnification. (D) Anchoring filaments (AF) from the overlying endothelium
are seen extending into the collagen substrate (Col). Scale bars A, B 0.5 mm, C, D 0.2 mm.
doi:10.1371/journal.pone.0050993.g008
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(Fig. 6A and B) or RAFT (Fig. 6C and D) after 4 days in culture.
This expression pattern was also seen after 14 days (Fig. 6E and F),
indicating that cells remain viable and maintain their typical
endothelial phenotype even after longer- term culture. Addition-
ally, the expression pattern of ZO-1 confirmed the typical
cobblestone appearance of hCECs on RAFT by labelling cell
junctions and borders. The isotype matched controls were
negative as expected (data not shown).
Ultrastuctural Properties of Endothelial Cells on RAFT
Scanning electron microscopy revealed the randomly orientated
collagen fibre structure of the seeding surface of RAFT (Fig. 7A). A
low magnification image of hCECs on the collagen surface showed
a confluent monolayer of polygonal cells (Fig. 7B) and at higher
magnification the tightly opposed borders were apparent (Fig. 7C),
additional evidence of typical endothelial morphology. Further
magnification reveals the highly interdigitated apical flaps of cell
borders and microvilli on the cell surface (Fig. 7D). Transmission
electron microscopy confirmed apical microvilli on the cell surface,
which leads to significant enlargement of cell surface area (Fig. 8A)
and tight junctions between adjacent cells (Fig. 8B and C).
Anchoring filaments protruding into RAFT were also identified,
which presumably aid attachment and security of the endothelial
layer to the underlying collagen substrate (Fig. 8D).
Discussion
The application of plastic compressed collagen for the culture of
human corneal endothelial cell layers offers an attractive
alternative for surgical restoration of corneal endothelium using
a simple and rapidly produced tissue engineered substrate. The
present study demonstrates that RAFT is a suitable substrate for
culture of corneal endothelial cells and additionally indicates that
this carrier has sufficient mechanical strength for transplantation
using current clinical delivery techniques. This feasibility study
provides encouraging evidence for further development using an
in vivo model to confirm endothelial functionality and RAFT
suitability in a living system.
Corneal endothelial cell loss or damage leads to stromal
oedema, loss of transparency, and will eventually lead to blindness.
The transplantation of a healthy endothelial layer is generally
required to reverse the oedema. The worldwide shortage of donor
corneal tissue has led to increased pressure to optimise protocols
for the reproducible expansion of endothelial cells in vitro to enable
development of tissue engineered endothelial constructs. Published
methods for isolation and expansion of endothelial cells vary
greatly between research groups [5], but success is difficult to
evaluate when donor variability is not taken into consideration.
Colleagues have evaluated the effectiveness of published culture
methods comparing the efficiency in supporting endothelial cell
growth from a single donor to eliminate the differences caused by
donor sample variability [7]. They compared four different cell
culture media after isolating cells using a two-step peel and digest
method and were able to determine the optimal culture medium
for expansion of cells. Endothelial cells were cultured for this study
using this method and it was found that cells could be expanded
from an initial starting number of approximately 36105 per donor
pair to between 6–156106 cells after only 2 passages (GS Peh and
JS Mehta, unpublished observation). In this study we were able to
seed human corneal endothelial cells at a concentration that
produced a final density of, on average, 1941.2 cells/mm2. This
figure is within range of the 2000 cells/mm2 minimum for
transplantation which is employed by 70% of European eye banks,
according to a 2010 European Eye Bank Association Directory
report [14]. Seeding at these densities with the number of cells
obtained from one cornea and estimating conservatively, this
could be equated to 20 RAFT preparations, 10 mm diameter in
size, meaning that one donor cornea pair could potentially treat 20
eyes, a dramatic improvement on the one to one approach with
whole tissue transplant.
The endothelial layer is at the boundary of the fluid filled
anterior chamber and a major function of the corneal endothelium
is to maintain corneal transparency by regulating corneal
hydration. The ‘‘leaky’’ barrier formed by the endothelial cells
allows aqueous humour to flow into the cornea to supply nutrients
to the avascular stroma and tight junctional proteins such as ZO-1,
expressed at lateral cell borders, are thought to regulate
paracellular permeability. The tendency for stromal swelling is
counteracted by the removal of excess fluid via Na+ K+ -ATPase
ionic pumps located on the lateral plasma membranes. Hence, the
expression of ZO-1 and Na+ K+ -ATPase, detected by antibodies,
in primary endothelial cells and endothelial cell lines in culture
supports the assumption that cells are exhibiting proper pump
function as seen in native tissue. Tissue engineering an endothelial
sheet ex vivo relies upon the fact that the cells can be expanded
in vitro, but this approach would fail if cells did not survive or lost
functional phenotype, i.e. expression of ZO-1 or Na+ K+ -ATPase,
during the time taken to expand to confluence or after deposition
on a carrier substrate. The culture of primary endothelial cells
in vitro is a considerable challenge, requiring specific knowledge
and skills and donor material of a particular specification. For
initial exploratory experiments to determine the suitability of
RAFT as a carrier for endothelial cells, a human corneal
endothelial cell line was used before use of primary endothelial
cells. We have shown that both the hCECL cells and primary
hCECs seeded onto RAFT attach and mature to form a stable
confluent monolayer after only 4 days in culture. Cells retained the
typical characteristics of endothelial cells including cobblestone
morphology and ultrastructural features of apical microvilli and
tight junctions between neighbouring cells and even after 14 days
were shown to retain expression of ZO-1 and Na+ K+ -ATPase.
This suggests that RAFT is a suitable substrate for long-term
culture of human endothelial cells for subsequent transplantation.
Additionally, this validates the use of the endothelial cell line as an
experimental alternative when it is not possible to culture primary
cells due to lack of suitable donor material or knowledge of the
complex culture protocols. A simple corneal endothelial tissue
equivalent suitable for many in vitro testing applications can be
rapidly created using the endothelial cell line with RAFT as the
stromal portion.
A number of different cell carriers have been trialled for the
purpose of endothelial layer construction but the possibilities are
limited by the specific requirements of a substrate in this context.
The required properties include; cytocompatibility, reproducibil-
ity, ease of production/supply, transparency, ability to be handled
easily by surgeons ideally with tuneable properties such as
thickness. Amongst the materials tested by others are bioengi-
neered materials such as collagen vitrigels [15], atellocollagen and
gelatin hydrogel sheets [16], silk fibroin [17], and tissues such as
the xenogeneic substrate of bovine corneal posterior lamellae [18],
human anterior lens capsule [19] and amniotic membrane [20].
Tissues such as amniotic membrane are beneficial, as they have
been widely used in ocular surgery and have already been proven
to successfully support the culture of other ocular cells such as
limbal epithelial cells ([21–24] and reviewed in [25]). However, the
donor variability between biological materials such as these
renders them unreliable and amniotic membrane in particular
displays sub-optimal transparency limiting its use in this context.
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An in vivo study using RAFT would provide important information
regarding degradation time in the presence of cells and anterior
chamber fluids as well as the effect of a functional endothelial layer
on RAFT transparency. Bioengineering a material is advanta-
geous as variability is limited and materials can be selected based
on their desirable properties. However, the gelatin and collagen
hydrogels and silk fibroin mats which have been trialled in this
area lack mechanical strength required for surgical use and can be
very fragile upon handling. Collagen vitrigels are also not ideal as
there is a relatively lengthy process involved in the production of
these materials (reviewed in [26]). The crucial advantage of our
RAFT biomaterial is the simple and rapid method of production,
which yields multiple reproducible constructs with limited
variability between batches. Additional advantages of the process
are that the properties of the material are tuneable allowing the
user to create constructs of varying thickness or collagen
concentration depending on the requirement. The mechanical
strength is sufficient to withstand the manipulation that would be
required for transplantation without the need for any chemical
crosslinking that may have deleterious effects on the behaviour of
cells on the surface or after transplantation. This was demonstrat-
ed by the successful loading and delivery of RAFT to an ex vivo
porcine eye using a clinical insertion device. Finally, one of the
unfavourable aspects of the DMEK procedure is that the isolated
membrane is prone to curling, making the tissue difficult to handle
even by experienced surgeons and so often leads to cell loss. RAFT
differs significantly in this area, showing no evidence of the
spontaneous curling that can lead to cell damage, allowing easy
handling during the transplantation procedure.
Conclusions
Human corneal endothelial cells cultured on RAFT retain their
endothelial characteristics on a biomaterial that has many
desirable physical properties allowing easy handling. This method
provides expanded human corneal endothelial cells with a suitable
substrate for transplantation so that one donor cornea could
potentially treat multiple patients requiring endothelial replace-
ment.
Acknowledgments
Thanks to The Lions Eye Institute for Transplantation and Research,
Tampa, FL, US for assistance with procurement of research grade donor
corneal tissue.
Author Contributions
Conceived and designed the experiments: HL GP RD JM JD AS.
Performed the experiments: HL GP K-PT RP AS. Analyzed the data: HL
GP. Contributed reagents/materials/analysis tools: HL GP RD JM JD AS.
Wrote the paper: HL GP JM JD K-PT RP AS.
References
1. Klintworth GK (2009) Corneal dystrophies. Orphanet J Rare Dis 4: 7.
2. Ham L, Dapena I, van Luijk C, van der Wees J, Melles GR (2009) Descemet
membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy:
review of the first 50 consecutive cases. Eye (Lond) 23: 1990–1998.
3. Mau K (2009) What DSAEK is going on? An alternative to penetrating
keratoplasty for endothelial dysfunction. Optometry 80: 513–523.
4. Heindl LM, Riss S, Bachmann BO, Laaser K, Kruse FE, et al. (2011) Split
cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue
cost and shortage. Ophthalmology 118: 294–301.
5. Peh GSL, Beuerman RW, Colman A, Tan DT, Mehta JS (2011) Human
corneal endothelial cell expansion for corneal endothelium transplantation: an
overview. Transplantation 91: 811–819.
6. Joyce NC, Meklir B, Joyce SJ, Zieske JD (1996) Cell cycle protein expression and
proliferative status in human corneal cells. Invest Ophthalmol Vis Sci 37: 645–
655.
7. Peh GS, Toh KP, Wu FY, Tan DT, Mehta JS (2011) Cultivation of human
corneal endothelial cells isolated from paired donor corneas. PLoS ONE 6:
e28310.
8. Senoo T, Joyce NC (2000) Cell cycle kinetics in corneal endothelium from old
and young donors. Invest Ophthalmol Vis Sci 41: 660–667.
9. Engelmann K, Friedl P (1989) Optimization of culture conditions for human
corneal endothelial cells. In Vitro Cell Dev Biol 25: 1065–1072.
10. Li W, Sabater AL, Chen YT, Hayashida Y, Chen SY, et al. (2007) A novel
method of isolation, preservation, and expansion of human corneal endothelial
cells. Invest Ophthalmol Vis Sci 48: 614–620.
11. Rose L, Kelliher C, Jun AS (2009) Endothelial keratoplasty: historical
perspectives, current techniques, future directions. Can J Ophthalmol 44:
401–405.
12. Levis HJ, Brown RA, Daniels JT (2010) Plastic compressed collagen as a
biomimetic substrate for human limbal epithelial cell culture. Biomaterials.
13. Engelmann K, Friedl P (1995) Growth of human corneal endothelial cells in a
serum-reduced medium. Cornea 14: 62–70.
14. Armitage WJ (2011) Preservation of Human Cornea. Transfus Med Hemother
38: 143–147.
15. Mimura T, Yamagami S, Yokoo S, Usui T, Tanaka K, et al. (2004) Cultured
human corneal endothelial cell transplantation with a collagen sheet in a rabbit
model. Invest Ophthalmol Vis Sci 45: 2992–2997.
16. Watanabe R, Hayashi R, Kimura Y, Tanaka Y, Kageyama T, et al. (2011) A
Novel Gelatin Hydrogel Carrier Sheet for Corneal Endothelial Transplantation.
Tissue engineering Part A.
17. Madden PW, Lai JNX, George KA, Giovenco T, Harkin DG, et al. (2011)
Human corneal endothelial cell growth on a silk fibroin membrane.
Biomaterials: 1–9.
18. Bayyoud T, Thaler S, Hofmann J, Maurus C, Spitzer MS, et al. (2012)
Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated
human corneal endothelial cells. Curr Eye Res 37: 179–186.
19. Yoeruek E, Saygili O, Spitzer MS, Tatar O, Bartz-Schmidt KU, et al. (2009)
Human anterior lens capsule as carrier matrix for cultivated human corneal
endothelial cells. Cornea 28: 416–420.
20. Ishino Y, Sano Y, Nakamura T, Connon CJ, Rigby H, et al. (2004) Amniotic
membrane as a carrier for cultivated human corneal endothelial cell
transplantation. Invest Ophthalmol Vis Sci 45: 800–806.
21. Nakamura T, Koizumi N, Tsuzuki M, Inoki K, Sano Y, et al. (2003) Successful
regrafting of cultivated corneal epithelium using amniotic membrane as a carrier
in severe ocular surface disease. Cornea 22: 70–71.
22. Schwab IR, Reyes M, Isseroff RR (2000) Successful transplantation of
bioengineered tissue replacements in patients with ocular surface disease.
Cornea 19: 421–426.
23. Tsai RJ-F, Li L-M, Chen J-K (2000) Reconstruction of damaged corneas by
transplantation of autologous limbal epithelial cells. New Engl J Med 343: 86–
93.
24. Shimazaki J, Aiba M, Goto E, Kato N, Shimmura S, et al. (2002)
Transplantation of human limbal epithelium cultivated on amniotic membrane
for the treatment of severe ocular surface disorders. Ophthalmology 109: 1285–
1290.
25. Shortt AJ, Secker GA, Lomas RJ, Wilshaw SP, Kearney JN, et al. (2009) The
effect of amniotic membrane preparation method on its ability to serve as a
substrate for the ex-vivo expansion of limbal epithelial cells. Biomaterials 30:
1056–1065.
26. Levis H, Daniels JT (2009) New technologies in limbal epithelial stem cell
transplantation. Current opinion in biotechnology 20: 593–597.
PC Collagen for Endothelial Transplantation
PLOS ONE | www.plosone.org 10 November 2012 | Volume 7 | Issue 11 | e50993
